Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs

a technology of exogenous and endogenous immune responses and materials, applied in the direction of immunological disorders, antibody medical ingredients, drug compositions, etc., can solve the problems of host immune responses that are formidable barriers to transplantation across species, patient's immune system is thoroughly compromised, and success is limited, so as to reduce the immune response, and reduce the immune response. effect of recipien

Inactive Publication Date: 2012-12-06
EDELMAN ELAZER R +2
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention is about using a biocompatible matrix with anchored or embedded endothelial cells, endothelial-like cells, or analogs thereof to reduce an immune response or inflammation in a recipient. This can be done by providing an implantable material containing the matrix and cells prior to transplantation or administration of a cell, tissue, or organ transplant. The cells can also be used to induce immunological acceptance in a patient. The invention can be used in the treatment of autoimmune diseases and can reduce the immunogenicity of donor antigens. The cells can be autogenic, allogenic, xenogeneic, or genetically-modified variants of any cell type. The invention can also be used to reduce the immune response to non-syngeneic cells, tissues, or organs. Overall, the invention provides a method for using endothelial cells to modulate the immune response and promote graft acceptance."

Problems solved by technology

However, host immune responses present a formidable barrier to transplantation across species.
While such agents permit some degree of transplant acceptance, success is limited and perhaps of more significance, a patient's immune system is thoroughly compromised as a result of such agents.
Similarly, exogenous immunogens or stimuli have posed a clinical challenge.
These, too, can result in adverse immunological events or inflammatory reactions which necessitate treatment.
Successful management of such diseases has eluded clinicians to date.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
  • Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
  • Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038]Tissue engineering is a promising approach to exploit endothelial cells, endothelial-like cells, or analogs of either as a cellular therapy for diseases accompanied by or typified by adverse immunological components. For example, certain diseases such as but not limited to vascular diseases provoke adverse immunological responses and / or inflammatory reactions. The present invention is based on the discovery that cells such as endothelial cells which are anchored to or embedded in three-dimensional matrices, secrete essential regulatory factors which can ameliorate or otherwise modulate an adverse immunological response.

[0039]The implantable material of the present invention was developed on the principals of tissue engineering and represents a novel approach to addressing the herein-described clinical needs. The implantable material of the present invention is unique in that the viable cells anchored to and / or embedded within the biocompatible matrix are able to supply to the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
humidityaaaaaaaaaa
humidityaaaaaaaaaa
pore sizeaaaaaaaaaa
Login to View More

Abstract

Disclosed herein are materials and methods for modulating an immunologically adverse response to an exogenous or endogenous immunogen, including a cell, tissue, or organ associated immunogen. An implantable material comprising cells, such as but not limited to endothelial cells, anchored or embedded in a biocompatible matrix can modulate an adverse immune or inflammatory reaction to exogenous or endogenous immunogens, including response to non-syngeneic or syngeneic cells, tissues or organs, exogenous immunogens or stimuli, as well as ameliorate an autoimmune condition. The implantable material can be provided prior to, coincident with, or subsequent to occurrence of the immune response or inflammatory reaction. The implantable material can induce immunological acceptance in a transplant patient, reduce graft rejection and reduce donor antigen immunogenicity.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. patent application Ser. No. 11 / 918,908, filed Dec. 19, 2007, which is a U.S. national phase application of International Patent Application No. PCT / US2006 / 015555, filed Apr. 21, 2006, which claims priority to and the benefit of U.S. Provisional Patent Application No. 60 / 673,417, filed Apr. 21, 2005, and U.S. Provisional Patent Application No. 60 / 682,217, filed May 18, 2005, the contents of each being incorporated by reference herein.FIELD OF THE INVENTION[0002]This invention is directed to materials and methods for modulating an immunologically adverse response to an exogenous or endogenous immunogen, including a cell-, tissue-, or organ-associated immunogen. For example, the present invention can modulate an adverse immune response or inflammatory reaction to exogenous or endogenous immunogens, including non-syngeneic or syngeneic cells, tissues or organs, as well as ameliorate an autoimmune con...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K35/12A61K9/00A61P37/02A61P29/00A61P37/06C12N5/071A61K35/44A61K39/00
CPCA61K39/001A61K2035/122C12N5/069A61K45/06A61K9/00A61K35/44C12N2533/54A61P29/00A61P37/02A61P37/06A61P43/00
Inventor EDELMAN, ELAZER R.NUGENT, HELEN MARIEMETHE, HEIKO
Owner EDELMAN ELAZER R
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products